Mayonnaise and salad dressing are fast becoming popular condiments for Malaysian. The aim of this study was to
obtain the nutritional composition of mayonnaise and salad dressing commercially available in the Malaysian market.
The data will be used to update the Malaysian Food Composition Database which was last updated in 1997. A total of
six brands from each type of mayonnaise and salad dressing were sampled from local supermarkets in the Klang Valley
and analysed using standard methods. The validity of test data was monitored with the application of internal quality
controls in line with the requirements of ISO 17025. The energy contents of mayonnaise and salad dressings were up to
626.40 kcal/100 g. Our findings were also in agreement with the energy labelling on the packaging. Sodium was high in
mayonnaise and salad dressing because it is used in the final mixture of both condiments to improve their characteristics
for certain reasons. Mayonnaise and salad dressing have been identified as potent sources of vitamin A and vitamin
E and both condiments were found to contain high levels of these antioxidants. It can be concluded that this study are
useful not only in providing information on the nutritional content of several commercial types of mayonnaise and salad
dressing, but also in improving the public understanding of healthy food choices.
Metabolic surgery is an essential option in the treatment of obese patients with type 2 diabetes (T2D). Despite its known advantages, this surgery still needs to be introduced in Malaysia. In this prospective study, the pathophysiological mechanisms at the molecular level will be studied and the metabolomics pathways of diabetes remission will be explored. The present study aims to evaluate the changes in the anthropometric measurements, body composition, phase angle, diet intake, biochemistry parameters, adipokines, microRNA, and metabolomics, both pre- and post-surgery, among obese diabetic patients in Malaysia. This is a multicenter prospective cohort study that will involve obese patients (n = 102) with a body mass index (BMI) of ≥25 kg/m2 (Asian BMI categories: WHO/IASO/IOTF, 2000) who will undergo metabolic surgery. They will be categorized into three groups: non-diabetes, prediabetes, and diabetes. Their body composition will be measured using a bioimpedance analyzer (BIA). The phase angle (PhA) data will be analyzed. Venous blood will be collected from each patient for glycated hemoglobin (HbA1c), lipids, liver, renal profile, hormones, adipokines, and molecular and metabolomics analyses. The serum microRNA will be measured. A gene expression study of the adipose tissue of different groups will be conducted to compare the groups. The relationship between the 1HNMR-metabolic fingerprint and the patients' lifestyles and dietary practices will be determined. The factors responsible for the excellent remission of T2D will be explored in this study.